Wtypes of bacterial vaccines, immunizing polysaccharides, " purified antigens," and other preparations of the typhoid bacillus intended for immunization against typhoid fever, there is an increasing need for a standard unit of immunogenic potency with which the effectiveness of these substances may be expressed. It is meaningless to assert that any one product is a certain number of times more effective than any other, particularly when the two substances have not been titrated for potency under a given set of conditions; and, even when substances have been titrated simultaneouslv, the validity of a mathematical ratio of effectiveness is open to question.
A much more useful and significant evaluation of the effectiveness of an immunogenic substance would be expressed in units of immunogenicity per unit of dry weight (or per unit of volume) of the product, determined under standard conditions with standardized materials. The problem resolves itself into defining such a unit of immunogenicity and describing materials and methods employed in its determination.
DEFINITI6N OF THE UNIT
The proposed unit is defined as fol- A preliminary exploratory titration is recommended before the actual test is made, by omitting alternate dilutions at the time the mice are injected, in order to orient the substance with a minimum of labor and materials. If the immunogen is already in the form of a solution or dispersion, it is treated in the same manner as the dispersion, described above.
Immunization of Test Animals-Individuals of respective groups of four mice each are inoculated intraperitoneally with 0.5 ml. amounts of each dilution. Sixteen mice from the same lot should be set aside for controls on the virulence of the test organism.
Test for Immunity-Seven days after immunization of mice, all animals that received the immunogen are inoculated intraperitoneally with 50,000 organisms of the challenging culture contained in 0.5 ml. of 5 per cent mucin. The normal control animals set aside at the beginning of the experiment are divided into four groups, the individuals of each group being inoculated with 5,000, 500, 50, and 5 organisms respectively. The latter inocula should be prepared by making serial 1 to 10 dilutions of the test dose material (50,000 organisms per 0.5 ml.) employed for determining immunity Qf the animals that received the immunogenic substance, and the estimated ntmbers of organisms should be contained in 0. Selection of the TIU value of typhoid vaccine from the following data is a simple matter. In each of the three instances, the m.l.d. of the test organism falls between 50 and 500 organisms, and 0.5 ml. amounts of the 1:100 dilution protected against the challenging dose of 50,000 organisms. This particular sample of typhoid vaccine, therefore, contains 200 TIU/ml.
As stated above, the vaccine contained 1,000 million typhoid bacilli per ml., and the weight of this number of or-
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Feh., 1945 Expressed as dry weight of organisms, the typhoid vaccine contained 200 TIU/0.2 mg., or 1000 TIU/mg. It must be remembered that these organisms had been treated with heat and phenol in their transition from the living state to a vaccine.
DISCUSSION
Some of the stipulations made under the headings of materials and procedures are so obviously essential for consistent results that they need no further comment, whereas the reasons for others may be somewhat obscure. Of the latter, the age of the test culture, the test dose of challenging organisms, the time interval between immunization and the test for immunity, and the " twice-repeated " test, probably deserve some explanation.
A 12 hour culture has been specified because of its high percentage of viable organisms and chiefly because of the consistent behavior (virulence) of organisms from such a culture experienced by us over a period of several years. It is as nearly a " constant " as could be expected and desired, considering the nature of such material. Maintenance of cultures by lyophilization is, of course, recommended.
The challenging dose of 50,000 organisms has been chosen also on the basis of experience, dating from our first titrations of Wakeman's polysaccharide in 1936 and 1937. This number (50,000) of organisms is sufficiently high to assure a dose of at least 50 m.l.d. even under unfavorably low temperatures of the animal room, yet, it will rarely exceed 500 m.l.d.; and the bulk of bacterial protein in 50,000 organisms is much too small seriously to affect the animal from the standpoint of toxicity. The test dose may therefore be considered as an infective or invasive dose, in contradistinction to a toxic dose, of the challenging organisms.
The 7 day interval between immunization and the test for immunity has been selected on the basis of much experimental work indicating that mice, after a single intraperitoneal injection of an immunogenic substance, quickly respond and reach the peak of their immunity within the first week.
Concerning the " twice-repeated" test, the objective of this repetition is confirmation. A (TIU) has been defined, and materials -and methods employed in its determination have been described. Adoption of the proposed method of titrating antityphoid immunogenic substances, and the computation of results in multiples of the proposed unit, would provide a standard technique for evaluating such substances and would provide a standard term for -the expression of their effectiveness. Much uncertainty regarding the relative value of antityphoid immunizing substances could thus be eliminated.
The proposed method is based on experience with this type of work and with the recommended materials, and has proved practical in all respects for conditions as they exist at the source of this paper. In the event that certain requirements would be difficult to meet in other laboratories performing such tests as this, modifications rendering the method more universallv acceptable may be necessary. The objective is to establish a procedure which will be reliable and practical in the hands of all workers engaged in the standardization of biologicals.
The foregoing proposal may also find application in the standardization of other bacterial vaccines and immunogenic products for which other methods have not been developed.
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